900 Shares in Markel Group Inc. $MKL Bought by Empowered Funds LLC

Key Points

• Empowered Funds LLC acquired 900 shares of Markel Group during the second quarter, valued at approximately $1.758 million. Institutional investors collectively own 77.12% of MKL.
• Markel shares opened at $1,845.86, with a market capitalization of $22.87 billion and a one-year trading range of $1,719.41 to $2,207.59.
• Analysts maintain a consensus “Hold” rating on MKL, with one Buy, four Hold, and one Sell rating and an average price target of $2,025.

Empowered Funds LLC acquired a new stake in Markel Group Inc. (NYSE:MKL - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 900 shares of the insurance provider's stock, valued at approximately $1,758,000.

Several other large investors have also bought and sold shares of MKL. Brighton Jones LLC acquired a new stake in shares of Markel Group in the fourth quarter valued at about $236,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Markel Group by 13.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 109 shares of the insurance provider's stock worth $204,000 after acquiring an additional 13 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Markel Group by 9.7% in the first quarter. Goldman Sachs Group Inc. now owns 34,704 shares of the insurance provider's stock worth $64,883,000 after acquiring an additional 3,083 shares during the period. Arrowstreet Capital Limited Partnership bought a new stake in Markel Group in the second quarter valued at approximately $463,000. Finally, Invesco Ltd. boosted its holdings in Markel Group by 15.6% in the second quarter. Invesco Ltd. now owns 20,043 shares of the insurance provider's stock valued at $40,033,000 after acquiring an additional 2,705 shares during the last quarter. 77.12% of the stock is owned by institutional investors.

Markel Group Stock Up 1.6%

Shares of NYSE:MKL opened at $1,845.86 on Friday. The company has a market capitalization of $22.87 billion, a price-to-earnings ratio of 10.15 and a beta of 0.65. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.63 and a quick ratio of 0.63. The business's 50-day moving average is $1,897.54 and its 200-day moving average is $1,904.22. Markel Group Inc. has a 1 year low of $1,719.41 and a 1 year high of $2,207.59.

Analysts Set New Price Targets

Several research analysts have issued reports on MKL shares. Wall Street Zen upgraded shares of Markel Group from a "sell" rating to a "hold" rating in a report on Saturday, August 1st. Weiss Ratings raised shares of Markel Group from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Monday, August 17th. Finally, Wolfe Research assumed coverage on shares of Markel Group in a research report on Wednesday, July 1st. They set an "underperform" rating for the company. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $2,025.00.

Markel Group Company Profile

Markel Group NYSE: MKL is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source